From: Integrins regulate stemness in solid tumor: an emerging therapeutic target
Integrin | Ligands/signaling partners | Cancer type | Function | References |
---|---|---|---|---|
β1 | Src/AKT | Lung | Promotes chemoresistance against EGFR inhibitor Erlotinib | [35] |
α2β1 | Collagen type I | Prostate | Promotes prostate cancer cell invasion and skeletal metastasis | [36] |
 | CDH-17 | Colon | Interacts with CDH17 to induce FAK and Ras activation and thus promotes tumor growth and liver metastasis | [37] |
α3β1 | Rho/Yap | CRPC | Suppresses anchorage-independent growth and metastasis | [38] |
α6 | AKT/ERK | Breast | Expresses highly in breast cancer vs. normal cells and enhances radiotherapy resistance | [39] |
α7 | Laminin | Glioblastoma | Correlates negatively with patient survival and promotes growth and invasiveness of CSCs | [40] |
α9β1 | β-catenin/E-cadherin | Lung | Promotes EMT, tumor growth, vasculogenesis and metastasis | [41] |
α10β1 | Collagen and Laminin | Glioblastoma | Upregulates in both glioblastoma tissue and cells, correlates with high-grade gliomas, and promotes cell proliferation and migration | [42] |
β3 | TGFβ | NSCLC | Accelerates cancer cell adhesion to lymphatic endothelium after TGF-β exposure, and combined targeting of β3 integrin and TGFβ reduces lymph node metastasis | [43] |
αvβ3 | OPN/FAK | NSCLC | Enhances cell proliferation and EGFR-TKI resistance | [44] |
 | Survivin | CRPC | Promotes anchorage-independent cell growth and enhances IR resistance via stabilization of Survivin | [45] |
 | KRAS/RalB | Lung/Breast/ Pancreas | Recruits KRAS and RalB to activate TBK1 and NF-κB, leading to enhanced stemness and RTK inhibitor resistance | [46] |
αvβ6 | MMP9 | SCC | Promotes invasion in an MMP9-dependent manner | [31] |
 | JNK1/Survivin | CRPC | Promotes anchorage-independent growth and cancer progression via activation of androgen receptor | [28] |
α6β4 | BNIP3L | TNBC | Induces BNIP3L-dependent mitophagy and lactate production in CAFs, which in turn promotes EMT, proliferation and invasion | [47] |
β8 | ECM | PDAC | Regulates positively cancer cell radiochemoresistance, intracellular vesicle trafficking, and autophagy | [48] |